- CA$2.29bn
- CA$3.92bn
- $3.61bn
Annual income statement for NFI, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2022 January 2nd | C2023 December 31st | R2023 January 1st | 2024 December 29th | 2025 December 28th | |
|---|---|---|---|---|---|
| Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,344 | 2,692 | 2,061 | 3,122 | 3,615 |
| Cost of Revenue | |||||
| Gross Profit | 187 | 221 | 49.1 | 349 | 270 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,298 | 2,705 | 2,349 | 3,016 | 3,605 |
| Operating Profit | 46 | -12.3 | -288 | 106 | 10 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.93 | -169 | -324 | -6.46 | -123 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -14.5 | -136 | -276 | -3.3 | -142 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -14.5 | -136 | -276 | -3.3 | -142 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -14.5 | -136 | -276 | -3.3 | -142 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.6 | -1.51 | -2.55 | 0.054 | -1.21 |
| Dividends per Share |